Michael Kahky, MD
Surgical Oncology · Orlando, FLNPI 1982706362
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (55.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 62.4% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2021 at $6,750 and has fallen 78.4% since, to $1,460 in 2025.
Across 43 payments — averaging $251.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$7K
- Axogen$2K
- Davol Inc.$1K
- Medtronic$411
- Daiichi Sankyo Inc.$256
- Medical Device Business Services, Inc.$100
- plus $456 from 14 others
What the payments were for
- Speaking & faculty fees$9909%
- Travel & lodging$2,29221%
- Food & beverage$1,53314%
- Education$6,00055%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 9 | $6,750 |
| Axogen | 6 | $1,787 |
| Davol Inc. | 2 | $1,055 |
| Medtronic | 7 | $411 |
| Daiichi Sankyo Inc. | 3 | $256 |
| Medical Device Business Services, Inc. | 1 | $100 |
| Merit Medical Systems Inc | 1 | $90 |
| Endomagnetics Ltd | 1 | $70 |
| Sobi, Inc | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Stryker | 1 | $31 |
| AstraZeneca | 1 | $28 |
| Agios Pharmaceuticals, Inc. | 1 | $26 |
| Novartis | 1 | $26 |
| Array Biopharma Inc | 1 | $24 |
| Blueprint Medicines Corporation | 1 | $23 |
| Merck | 1 | $19 |
| Genentech USA, Inc. | 1 | $17 |
| Geron Corporation | 1 | $15 |
| GSK | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,815 in reported general payments places this provider in the 75th percentile of 133 surgical oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 82 | $254 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 11 | $54 |
| Methocarbamol | 12 | $45 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Orlando
- Debashish BoseOrlando$14K
- Rajesh NairOrlando$13K
- Margaret ShoupOrlando$7K
- Neha GoelMiami$200K
- Jonathan ZagerTampa$191K
- Horacio AsbunMiami$161K
- Adrian Legaspi SauterHialeah$116K
- Kenneth MeredithSarasota$113K
- Pamela HodulTampa$94K
- Mehran HabibiMiami$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.